PerspectivePharmaceutical Toxicity

Improving Risk Assessment

Science Translational Medicine  07 Nov 2012:
Vol. 4, Issue 159, pp. 159ps22
DOI: 10.1126/scitranslmed.3003497

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Widespread sharing and analysis of clinical trial data and a U.S. government initiative to engineer nonclinical cell-based models that mimic human biological processes have the potential to improve predictions of drug-related adverse events.

View Full Text

Related Content